Valuation: Chongqing Jiheng Pharmaceutical Co., Ltd.

Market Cap 2.24B 330M 292M 271M 249M 466M 31.9B 473M 3.22B 1.26B 15.69B 1.24B 1.21B 54.11B P/E 2024
-2.74x
P/E 2025 -7.41x
Enterprise Value 2.65B 391M 345M 321M 294M 551M 37.77B 560M 3.81B 1.49B 18.57B 1.47B 1.44B 64.07B EV / Sales 2024
2.87x
EV / Sales 2025 3.89x
Free-Float
54.43%
Yield 2024 *
-
Yield 2025 -
04-24 Chongqing Sansheng Industrial Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2026 CI
03-29 Chongqing Sansheng Industrial Co.,Ltd. agreed to acquire an additional 11.94% stake in Chongqing Chunrui Pharmaceutical and Chemical Co., Ltd. from Hao Tingyan. CI
03-16 Chongqing Sansheng Industrial Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2025 CI
25-10-28 Chongqing Sansheng Industrial Co.,Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2025 CI
25-08-26 Chongqing Sansheng Industrial Co.,Ltd. Reports Earnings Results for the Half Year Ended June 30, 2025 CI
25-07-03 Zhang Yanning and Cen Yetao completed the acquisition of 7.45% stake in Chongqing Sansheng Industrial Co.,Ltd. from Pan Xianwen for approximately CNY 110 million. CI
25-07-01 Zhang Yanning and Cen Yetao agreed to acquire 7.45% stake in Chongqing Sansheng Industrial Co.,Ltd. from Pan Xianwen for approximately CNY 110 million. CI
25-07-01 Zhang Yanning and Cen Yetao agreed to acquire 7.45% stake in Chongqing Sansheng Industrial Co.,Ltd. from Pan Xianwen for approximately CNY 110 million. CI
25-04-25 Chongqing Sansheng Industrial Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2025 CI
25-04-25 Chongqing Sansheng Industrial Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2024 CI
25-04-24 Chongqing Sansheng Industrial Co.,Ltd. Auditor Raises 'Going Concern' Doubt CI
24-10-29 Chongqing Sansheng Industrial Co.,Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2024 CI
24-08-27 Chongqing Sansheng Industrial Co.,Ltd. Reports Earnings Results for the Half Year Ended June 30, 2024 CI
1 day-3.82%
1 week-10.66%
Current month-2.39%
1 month-9.17%
3 months-30.57%
6 months-24.83%
Current year-27.65%
1 week 3.18
Extreme 3.18
3.6
1 month 3.18
Extreme 3.18
3.88
Current year 3.18
Extreme 3.18
5.26
1 year 3.18
Extreme 3.18
6.09
3 years 1.24
Extreme 1.24
6.09
5 years 1.24
Extreme 1.24
7.83
10 years 1.24
Extreme 1.24
31.05
Manager TitleAgeSince
Chief Executive Officer 59 2010-02-28
Director of Finance/CFO 52 2023-04-20
Chief Tech/Sci/R&D Officer 49 -
Director TitleAgeSince
Director/Board Member 54 2017-03-15
Director/Board Member 74 -
Director/Board Member 59 2010-02-28
Change 5-day change 1-year change 3-year change Capi.($)
-3.82%-10.66%-33.27%-17.01% 343M
+0.86%+2.30%+49.71%+158.86% 1,057B
+1.59%+5.37%+55.77%+54.77% 624B
+0.95%+1.95%+36.11%+80.44% 454B
+1.60%+7.09%+35.90%+29.32% 341B
-0.60%+2.95%+36.28%+39.04% 297B
-0.14%+0.33%+18.70%+17.64% 262B
+0.09%-4.53%-27.60%-42.19% 215B
+1.22%+1.20%+21.61%+60.14% 201B
-1.18%-5.13%+13.87%+60.35% 162B
Average -0.22%+0.31%+20.71%+44.14% 361.43B
Weighted average by Cap. +0.04%+1.57%+36.61%+76.82%

Financials

2024 2025
Net sales 1.2B 177M 156M 145M 133M 249M 17.05B 253M 1.72B 674M 8.38B 663M 649M 28.92B 900M 133M 117M 109M 100M 187M 12.83B 190M 1.3B 507M 6.31B 499M 488M 21.77B
Net income -650M -96.01M -84.72M -78.76M -72.28M -135M -9.27B -138M -936M -367M -4.56B -360M -353M -15.73B -420M -61.98M -54.69M -50.84M -46.66M -87.36M -5.98B -88.81M -604M -237M -2.94B -233M -228M -10.15B
Net Debt 1.66B 245M 217M 201M 185M 346M 23.69B 352M 2.39B 937M 11.65B 921M 901M 40.19B 412M 60.79M 53.64M 49.86M 45.76M 85.68M 5.87B 87.1M 593M 232M 2.89B 228M 223M 9.96B
Logo Chongqing Jiheng Pharmaceutical Co., Ltd.
Chongqing Jiheng Pharmaceutical Co Ltd, formerly Chongqing Sansheng Industrial Co Ltd is a China-based company primarily engaged in building materials and chemical, and pharmaceutical manufacturing businesses. The Company operates two main businesses. The building materials and chemical business is primarily engaged in the production and sales of ready-mixed concrete, water-reducing agents, expanding agents and sulfuric acid. The pharmaceutical manufacturing business is primarily engaged in the production and sales of pharmaceutical intermediates such as procaine hydrochloride and cefoxitin intermediates, active pharmaceutical ingredients (APIs) such as acetaminophen and clopidogrel hydrochloride, and pharmaceutical preparations such as compound acetaminophen and diphenhydramine tablets, and clopidogrel hydrochloride tablets. The Company conducts its businesses in the domestic market and overseas markets.
Employees
979
Date Price Change Volume
26-07-24 CN¥3.270 -3.82% 6,576,200
26-07-23 CN¥3.400 +3.66% 8,028,936
26-07-22 CN¥3.280 -0.91% 8,775,400
26-07-21 CN¥3.310 -2.65% 11,925,500
26-07-20 CN¥3.400 -2.30% 12,977,100
  1. Stock Market
  2. Stocks
  3. 002742 Stock